Preclinical efficacy of the GPER-selective agonist G-1 in mouse models of obesity and diabetes.
Sharma G, Hu C, Staquicini DI, Brigman JL, Liu M, Mauvais-Jarvis F, Pasqualini R, Arap W, Arterburn JB, Hathaway HJ, Prossnitz ER.
Sharma G, et al. Among authors: pasqualini r.
Sci Transl Med. 2020 Jan 29;12(528):eaau5956. doi: 10.1126/scitranslmed.aau5956.
Sci Transl Med. 2020.
PMID: 31996464
Free PMC article.